ArticleBMC women's health2025
Clinical effect of ultrasound-guided microwave ablation in the treatment of 60 patients with non-puerperal mastitis.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe incidence of non-puerperal mastitis (NPM) is increasing but treatment is not consistent, and relapse is common.
objectiveTo investigate the clinical effect of ultrasound-guided microwave ablation in the treatment of NPM.
methodsWe retrospectively analysed the data of 60 patients with NPM who had undergone microwave ablation treatment at the Nantong University Affiliated Hospital from September 2020 to June 2022. Among them, 20 (33.3%) opted for outpatient treatment, and 40 (66.7%) were treated as inpatients. The mean age of the patients was 34 ± 8.74 years. The duration of follow-up was 6-18 (median: 9) months. Follow-up parameters included time to remission of acute clinical symptoms, breast ultrasonography findings, breast skin appearance and beauty scores, patient satisfaction, adverse events, and recurrence rates.
resultsAll 60 patients were successfully treated with microwave ablation. During the follow-up, ultrasound showed that the average maximum diameter of the lesions gradually decreased while the echogenicity of the lesions gradually increased. The time to clinical relief from acute symptoms was 10.78 ± 8.86 days. The cure rate was 93.3% (56/60), and the improvement rate was 6.7% (4/60). The breast appearance beauty score was 8.45 ± 1.17, the patient satisfaction rate was 93.3% (56/60), the incidence of adverse events was 31.7% (19/60), and the recurrence rate was 1.67% (1/60).
conclusionMicrowave ablation is a direct and effective method for the treatment of NPM, with significant curative effects, less trauma, quick recovery, high patient satisfaction, and low recurrence rate. Thus, it provides clinicians with a new option to treat NPM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.